Company profile
Doximity, Inc.
NYSE: DOCS · Healthcare · Medical - Healthcare Information Services
#191 of 1,422 Healthcare companies by revenue59th-percentile growth
EA Score
73BFH 93DQ 49GM 66SS 65
v0.1 · 65/100 weight · provisional
↑ operating margin, net margin · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$644.9M
Rev growth YoY (TTM)
+13.1%
Net income (FY)
$196.1M
Employees
880
as of 2026-08-07
Market cap
$3.9B
as of 2026-08-07
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$644.9M$644.9M2026
Net income$196.1M$196.1M2026
Operating income$214.9M$214.9M2026
Total assets$1.1B$1.1B2026
Liabilities$172.8M$172.8M2026
Equity$950.8M$950.8M2026
Revenue trend
FY2022 – FY2026 · USD
FY22
FY22
FY22
FY23
FY24
FY25
FY26
Revenue by segment
Filed disclosures · FY2026
By product
Subscription94%
Service, Other6%
By geography
Not disclosed.
The read
What is Doximity, Inc.’s revenue?
Doximity, Inc. booked $644.9M in FY2026 revenue, growing 13% year over year — about the middle of the pack among Healthcare companies we track, at a 30.4% net margin.
Peers · Healthcare
Avanos Medical, Inc.73BUltragenyx Pharmaceutical Inc.58CCresco Labs Inc.37D10x Genomics, Inc.67BAxsome Therapeutics, Inc.59CTG Therapeutics, Inc.72BNeighbors
San Francisco →Key facts
CEOJeffrey A. Tangney
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersSan Francisco, CA
ExchangeNYSE: DOCS
Employees880
IPO date2021-06-24
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.